Making an Impact
We “translate” vaccines into practical tools for public health. To this end, we facilitate the introduction of new licensed vaccines in countries where they are needed by generating scientific data on the need for vaccines and the impact of vaccination, and by sharing this data with donors, decision makers and governments for policy and action.
What We Do
- Disease burden and health economics studies to provide evidence of the need and demand for vaccines.
- Demonstration projects and other studies to measure clinical impact, logistical feasibility, costs, and cost-effectiveness of vaccination.
- Data synthesis and analysis (e.g., vaccine investment cases) to inform decision-making about the introduction of new vaccines.
Generating Evidence on Disease Burden in the Developing World
We focus on infectious disease surveillance, disease burden and epidemiologic studies. A core element of our work is providing support and technical assistance to developing countries in their disease surveillance and reporting. This data and the capacity to generate such data is crucial in demonstrating the need for vaccines and vaccinations to donors, policymakers and governments.
- Capacity-building for Japanese encephalitis and Hib surveillance in North Korea in collaboration with the North Korean Academy of Medical Sciences (AMS), supported by the Korean Ministry of Unification.
- Typhoid Surveillance in sub-Saharan Africa Program (TSAP) supported by the Bill & Melinda Gates Foundation.